insights_auto
Why is ALNY up 3,63%?
Dive Deeperchevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
232,68 USD
arrow_upward
+3,63%(+8,15) 1D
9-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNY...
Open
224,74 USD
High
232,94 USD
Low
222,70 USD
Mkt. cap
31,13 млд
Avg. vol.
1,50 млн
Volume
23,00
P/E ratio
39,60
52-wk high
495,55 USD
52-wk low
197,81 USD
EPS
5,88 USD
Beta
0,28
Shares outstanding
133,81 млн
No. of employees
2 миң
Open
224,74 USD
High
232,94 USD
Low
222,70 USD
Mkt. cap
31,13 млд
Avg. vol.
1,50 млн
Volume
23,00
P/E ratio
39,60
52-wk high
495,55 USD
52-wk low
197,81 USD
EPS
5,88 USD
Beta
0,28
Shares outstanding
133,81 млн
No. of employees
2 миң
News stories
From web sources and news partners
Investing.com
·
20 саат мурун
Alnylam EVP Bryan Supran sells $398,855 in shares
Investing.com Nigeria
·
20 саат мурун
Form 4 Alnylam Pharmaceuticals Inc For: 11 October By Investing.com
Simply Wall Street
·
21 саат мурун
How Securities Fraud Scrutiny Will Impact Alnylam Stock Investors
Stock Traders Daily
·
2 күн мурун
(ALNY) Price Dynamics and Execution-Aware Positioning
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.